Press release
Hereditary Angioedema Market: Global Industry Growth Analysis, Trends, Competitive Landscape and Forecasts to 2021
Complete report available at http://www.marketreportsonline.com/584779.html.
The report also includes a detailed regional analysis of the US and Europe hereditary angioedema market comprising of hereditary market by value, segments and growth. Under competitive landscape different products in the global hereditary angioedema market have been compared on basis of various technical parameters.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global hereditary angioedema market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Shire Plc, iBio, Inc., Pharming Group NV and CSL Limited are some of the key players operating in the global hereditary angioedema market whose company profiling is done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.
Order a copy of this “Hereditary Angioedema Market” research report at http://www.marketreportsonline.com/contacts/purchase.php?name=584779.
Angioedema can be defined as a disorder in which there is a rapid inflammation of the dermis, subcutaneous tissue, mucosa (cavities surrounding internal organs) and sub mucosal tissues. Angioedema can further be divided into acquired and hereditary angioedema. Acquired angioedema is generally caused due to allergy. On the other hand, hereditary angioedema is caused due to genetic mutation.
Hereditary angioedema (HAE) is defined as a condition highlighted by frequent incidences of severe swelling. It is a rarely inherited disorder. It most commonly affects limbs, face, intestinal and respiratory tract and causes severe swelling in these parts of the body. Low levels of C1 inhibitor, a protein leads to the over activation of bradykinin. Bradykinin is a chemical which is the prime cause the occurrence of angioedema.
The global hereditary angioedema market is projected to increase at a healthy rate during the forecasted period (2017-2021). This growth is expected on account of many growth drivers such as increased diagnosis in the US and Europe, advantages of preventive therapy, approval of Berinert for pediatric treatment, launch of Haegarda C1 inhibitor and some other major products in the pipeline.
However, the market also faces certain challenges such as high prophylaxis cost, side effects of Cinryze and long term prophylactic treatment. Oral therapy for hereditary angioedema attacks and SHP643 monoclonal antibody are some of the trends in the global hereditary angioedema market.
Explore more latest reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Market: Global Industry Growth Analysis, Trends, Competitive Landscape and Forecasts to 2021 here
News-ID: 587965 • Views: …
More Releases from MarketReportsOnline
US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is…
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,…
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.…
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021.
The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,…
More Releases for Angioedema
Angioedema Treatment Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Angioedema Treatment market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This report is…
Hereditary Angioedema Therapeutics Market - Forecast to 2026
As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead.
Browse 153 Market Data Tables and 113 Figures spread through…
Hereditary Angioedema Market Global Comprehensive Research 2020
Global Hereditary Angioedema Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Hereditary Angioedema Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes…
Angioedema Market: Rampant Allergies to Bolster Angioedema Treatment
Angioedema, an edema of spots beneath the skin or mucosa aggravating throat, face, limbs and genitals has taken the lives of more than five thousand people between 1979 and 2010. Unlike urticarial that attacks merely the upper dermis, angioedema strikes the deeper layers, including the dermis, the mucosa, submucosal tissues and the subcutaneous tissue. These assimilations are according to the report titled “Angioedema Market,” which has been recently added to…
Angioedema Market: Rampant Allergies to Bolster Angioedema Treatment
Angioedema, an edema of spots beneath the skin or mucosa aggravating throat, face, limbs and genitals has taken the lives of more than five thousand people between 1979 and 2010. Unlike urticarial that attacks merely the upper dermis, angioedema strikes the deeper layers, including the dermis, the mucosa, submucosal tissues and the subcutaneous tissue. These assimilations are according to the report titled “Angioedema Market,” which has been recently added to…
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc.
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016.
Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html
Superior Healthcare…
